[Finger tip necroses after dihydroergotamine medication in limited systemic scleroderma].
Copyright policy )[Finger tip necroses after dihydroergotamine medication in limited systemic scleroderma].
A 78 year old women developed acute fingertip necrosis just a few days after starting dihydroergotamine. The lesions healed in 3 weeks after the medication was stopped. The patient had suffered from Raynaud syndrome for 5 years and limited systemic sclerosis was diagnosed during the necrotic episode. Advanced age and microangiopathies are contraindications to the use of ergot-containing preparations.
Scleroderma, Systemic, Dose-Response Relationship, Drug, Contraindications, Migraine Disorders, Raynaud Disease, Drug Administration Schedule, Fingers, Necrosis, Risk Factors, Humans, Female, Dihydroergotamine, Aged
Scleroderma, Systemic, Dose-Response Relationship, Drug, Contraindications, Migraine Disorders, Raynaud Disease, Drug Administration Schedule, Fingers, Necrosis, Risk Factors, Humans, Female, Dihydroergotamine, Aged
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).5 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Average influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Average
Citations provided by BIP!Popularity provided by BIP!